PROLOR Biotech

Financials

Income Statement

Balance Sheet

Cash Flow

Quarterly Data

Annual Data

In Millions of USD (except for per share items)	3 months ending 2012-12-31	3 months ending 2012-09-30	3 months ending 2012-06-30	3 months ending 2012-03-31
Revenue	0.00	0.00	0.00	0.00
Other Revenue, Total	-	-	-	-
Total Revenue	0.00	0.00	0.00	0.00
Cost of Revenue, Total	-	-	-	-
Gross Profit	0.00	0.00	0.00	0.00
Selling/General/Admin. Expenses, Total	0.36	0.87	0.86	0.64
Research & Development	2.80	4.73	2.13	4.30
Depreciation/Amortization	1.07	-	-	0.00
Interest Expense(Income) - Net Operating	-	-	-	-
Unusual Expense (Income)	0.00	0.00	0.00	0.00
Other Operating Expenses, Total	0.48	-	-	0.15
Total Operating Expense	4.71	5.60	2.99	5.09
Operating Income	-4.71	-5.60	-2.99	-5.09
Interest Income(Expense), Net Non-Operating	-	-	-	-
Gain (Loss) on Sale of Assets	-	-	-	-
Other, Net	-	-	-	-
Income Before Tax	-4.70	-5.50	-3.07	-5.00
Income After Tax	-4.70	-5.50	-3.07	-5.00
Minority Interest	-	-	-	-
Equity In Affiliates	-	-	-	-
Net Income Before Extra. Items	-4.70	-5.50	-3.07	-5.00
Accounting Change	-	-	-	-
Discontinued Operations	-	-	-	-
Extraordinary Item	-	-	-	-
Net Income	-4.70	-5.50	-3.07	-5.00
Preferred Dividends	-	-	-	-
Income Available to Common Excl. Extra Items	-4.70	-5.50	-3.07	-5.00
Income Available to Common Incl. Extra Items	-4.70	-5.50	-3.07	-5.00
Basic Weighted Average Shares	-	-	-	-
Basic EPS Excluding Extraordinary Items	-	-	-	-
Basic EPS Including Extraordinary Items	-	-	-	-
Dilution Adjustment	0.00	0.00	0.00	0.00
Diluted Weighted Average Shares	63.53	63.40	59.31	54.73
Diluted EPS Excluding Extraordinary Items	-0.07	-0.09	-0.05	-0.09
Diluted EPS Including Extraordinary Items	-	-	-	-
Dividends per Share - Common Stock Primary Issue	0.00	0.00	0.00	0.00
Gross Dividends - Common Stock	-	-	-	-
Net Income after Stock Based Comp. Expense	-	-	-	-
Basic EPS after Stock Based Comp. Expense	-	-	-	-
Diluted EPS after Stock Based Comp. Expense	-	-	-	-
Depreciation, Supplemental	-	-	-	-
Total Special Items	-	-	-	-
Normalized Income Before Taxes	-	-	-	-
Effect of Special Items on Income Taxes	-	-	-	-
Income Taxes Ex. Impact of Special Items	-	-	-	-
Normalized Income After Taxes	-	-	-	-
Normalized Income Avail to Common	-	-	-	-
Basic Normalized EPS	-	-	-	-
Diluted Normalized EPS	-0.07	-0.09	-0.05	-0.09

In Millions of USD (except for per share items)	12 months ending 2012-12-31	12 months ending 2011-12-31	12 months ending 2010-12-31	12 months ending 2009-12-31
Revenue	0.00	0.00	0.00	0.00
Other Revenue, Total	-	-	-	-
Total Revenue	0.00	0.00	0.00	0.00
Cost of Revenue, Total	-	-	-	-
Gross Profit	-	-	-	0.00
Selling/General/Admin. Expenses, Total	4.07	3.87	2.78	1.90
Research & Development	14.32	10.98	4.90	5.26
Depreciation/Amortization	-	-	-	0.30
Interest Expense(Income) - Net Operating	-	-	-	-
Unusual Expense (Income)	-	-	-	0.00
Other Operating Expenses, Total	-	-	-	-
Total Operating Expense	18.39	14.85	7.68	7.46
Operating Income	-18.39	-14.85	-7.68	-7.46
Interest Income(Expense), Net Non-Operating	-	-	-	-
Gain (Loss) on Sale of Assets	-	-	-	-
Other, Net	-	-	-	-
Income Before Tax	-18.27	-15.06	-7.56	-7.48
Income After Tax	-18.27	-15.06	-7.56	-7.48
Minority Interest	-	-	-	-
Equity In Affiliates	-	-	-	-
Net Income Before Extra. Items	-18.27	-15.06	-7.56	-7.48
Accounting Change	-	-	-	-
Discontinued Operations	-	-	-	-
Extraordinary Item	-	-	-	-
Net Income	-18.27	-15.06	-7.56	-7.48
Preferred Dividends	-	-	-	-
Income Available to Common Excl. Extra Items	-18.27	-15.06	-7.56	-7.48
Income Available to Common Incl. Extra Items	-18.27	-15.06	-7.56	-7.48
Basic Weighted Average Shares	-	-	-	-
Basic EPS Excluding Extraordinary Items	-	-	-	-
Basic EPS Including Extraordinary Items	-	-	-	-
Dilution Adjustment	0.00	0.00	0.00	0.00
Diluted Weighted Average Shares	60.24	51.96	40.03	35.55
Diluted EPS Excluding Extraordinary Items	-0.30	-0.29	-0.19	-0.21
Diluted EPS Including Extraordinary Items	-	-	-	-
Dividends per Share - Common Stock Primary Issue	0.00	0.00	0.00	0.00
Gross Dividends - Common Stock	-	-	-	-
Net Income after Stock Based Comp. Expense	-	-	-	-
Basic EPS after Stock Based Comp. Expense	-	-	-	-
Diluted EPS after Stock Based Comp. Expense	-	-	-	-
Depreciation, Supplemental	-	-	-	-
Total Special Items	-	-	-	-
Normalized Income Before Taxes	-	-	-	-
Effect of Special Items on Income Taxes	-	-	-	-
Income Taxes Ex. Impact of Special Items	-	-	-	-
Normalized Income After Taxes	-	-	-	-
Normalized Income Avail to Common	-	-	-	-
Basic Normalized EPS	-	-	-	-
Diluted Normalized EPS	-0.30	-0.29	-0.19	-0.21

In Millions of USD (except for per share items)	As of 2012-12-31	As of 2012-09-30	As of 2012-06-30	As of 2012-03-31
Cash & Equivalents	23.85	28.57	26.62	7.25
Short Term Investments	10.06	10.75	15.84	1.88
Cash and Short Term Investments	33.91	39.32	42.45	9.13
Accounts Receivable - Trade, Net	0.28	0.17	0.48	0.35
Receivables - Other	-	-	-	-
Total Receivables, Net	0.28	0.17	0.48	0.35
Total Inventory	-	-	-	-
Prepaid Expenses	0.12	0.18	0.01	0.03
Other Current Assets, Total	0.14	0.06	0.06	0.00
Total Current Assets	34.44	39.73	43.00	9.52
Property/Plant/Equipment, Total - Gross	1.64	1.51	1.44	1.41
Accumulated Depreciation, Total	-0.62	-0.56	-0.50	-0.45
Goodwill, Net	-	-	-	-
Intangibles, Net	0.14	-	-	-
Long Term Investments	-	-	-	-
Other Long Term Assets, Total	0.31	0.29	0.26	0.32
Total Assets	35.92	40.97	44.20	10.80
Accounts Payable	1.14	0.50	0.22	1.05
Accrued Expenses	1.20	2.55	1.03	1.02
Notes Payable/Short Term Debt	0.00	0.00	0.00	0.00
Current Port. of LT Debt/Capital Leases	-	-	-	-
Other Current liabilities, Total	-	-	-	-
Total Current Liabilities	2.34	3.05	1.25	2.07
Long Term Debt	-	-	-	-
Capital Lease Obligations	-	-	-	-
Total Long Term Debt	0.00	0.00	0.00	0.00
Total Debt	0.00	0.00	0.00	0.00
Deferred Income Tax	-	-	-	-
Minority Interest	-	-	-	-
Other Liabilities, Total	0.38	0.35	0.33	0.33
Total Liabilities	2.72	3.40	1.58	2.40
Redeemable Preferred Stock, Total	-	-	-	-
Preferred Stock - Non Redeemable, Net	-	0.00	0.00	0.00
Common Stock, Total	0.00	0.00	0.00	0.00
Additional Paid-In Capital	101.12	100.79	100.34	63.05
Retained Earnings (Accumulated Deficit)	-67.92	-63.22	-57.72	-54.65
Treasury Stock - Common	-	-	-	-
Other Equity, Total	-	-	-	-
Total Equity	33.20	37.58	42.62	8.40
Total Liabilities & Shareholders' Equity	35.92	40.97	44.20	10.80
Shares Outs - Common Stock Primary Issue	-	-	-	-
Total Common Shares Outstanding	63.41	63.41	63.40	54.81

In Millions of USD (except for per share items)	As of 2012-12-31	As of 2011-12-31	As of 2010-12-31	As of 2009-12-31
Cash & Equivalents	23.85	13.26	24.08	3.52
Short Term Investments	10.06	0.14	1.44	0.00
Cash and Short Term Investments	33.91	13.40	25.52	3.52
Accounts Receivable - Trade, Net	0.28	0.33	0.64	0.05
Receivables - Other	-	-	-	-
Total Receivables, Net	0.28	0.33	0.64	0.05
Total Inventory	-	-	-	-
Prepaid Expenses	0.12	-	-	0.04
Other Current Assets, Total	0.14	0.10	0.03	0.09
Total Current Assets	34.44	13.83	26.19	3.70
Property/Plant/Equipment, Total - Gross	1.64	1.16	0.56	0.43
Accumulated Depreciation, Total	-0.62	-0.40	-0.30	-0.21
Goodwill, Net	-	-	-	-
Intangibles, Net	0.14	0.13	0.09	0.07
Long Term Investments	-	-	-	-
Other Long Term Assets, Total	0.31	0.30	0.27	0.13
Total Assets	35.92	15.02	26.81	4.11
Accounts Payable	1.14	0.58	0.24	0.34
Accrued Expenses	1.20	1.64	1.35	0.48
Notes Payable/Short Term Debt	0.00	0.00	0.00	0.00
Current Port. of LT Debt/Capital Leases	-	-	-	-
Other Current liabilities, Total	-	-	-	0.02
Total Current Liabilities	2.34	2.22	1.60	0.84
Long Term Debt	-	-	-	-
Capital Lease Obligations	-	-	-	-
Total Long Term Debt	0.00	0.00	0.00	0.00
Total Debt	0.00	0.00	0.00	0.00
Deferred Income Tax	-	-	-	-
Minority Interest	-	-	-	-
Other Liabilities, Total	0.38	0.28	0.22	0.14
Total Liabilities	2.72	2.50	1.82	0.98
Redeemable Preferred Stock, Total	-	-	-	-
Preferred Stock - Non Redeemable, Net	-	0.00	0.00	0.00
Common Stock, Total	0.00	0.00	0.00	0.00
Additional Paid-In Capital	101.12	62.17	59.58	30.15
Retained Earnings (Accumulated Deficit)	-67.92	-49.65	-34.58	-27.02
Treasury Stock - Common	-	-	-	-
Other Equity, Total	-	-	-	-
Total Equity	33.20	12.52	24.99	3.13
Total Liabilities & Shareholders' Equity	35.92	15.02	26.81	4.11
Shares Outs - Common Stock Primary Issue	-	-	-	-
Total Common Shares Outstanding	63.41	54.57	54.12	35.57

In Millions of USD (except for per share items)	12 months ending 2012-12-31	9 months ending 2012-09-30	6 months ending 2012-06-30	3 months ending 2012-03-31
Net Income/Starting Line	-18.27	-13.57	-8.07	-5.00
Depreciation/Depletion	0.22	0.16	0.10	0.05
Amortization	-	-	-	-
Deferred Taxes	-	-	-	-
Non-Cash Items	1.61	1.19	0.74	0.39
Changes in Working Capital	0.05	0.87	-1.08	-0.15
Cash from Operating Activities	-16.39	-11.35	-8.31	-4.71
Capital Expenditures	-0.48	-0.22	-0.15	-0.12
Other Investing Cash Flow Items, Total	-9.97	-10.56	-15.62	-1.67
Cash from Investing Activities	-10.46	-10.77	-15.77	-1.79
Financing Cash Flow Items	0.00	0.00	0.00	0.00
Total Cash Dividends Paid	-	-	-	-
Issuance (Retirement) of Stock, Net	37.43	37.43	37.43	0.49
Issuance (Retirement) of Debt, Net	-	0.00	0.00	0.00
Cash from Financing Activities	37.43	37.43	37.43	0.49
Foreign Exchange Effects	-	-	-	-
Net Change in Cash	10.59	15.31	13.36	-6.01
Cash Interest Paid, Supplemental	0.00	0.00	0.00	0.00
Cash Taxes Paid, Supplemental	0.00	0.00	0.00	0.00

In Millions of USD (except for per share items)	12 months ending 2012-12-31	12 months ending 2011-12-31	12 months ending 2010-12-31	12 months ending 2009-12-31
Net Income/Starting Line	-18.27	-15.06	-7.56	-7.48
Depreciation/Depletion	0.22	0.17	0.09	0.08
Amortization	-	-	-	-
Deferred Taxes	-	-	-	-
Non-Cash Items	1.61	1.98	0.96	0.78
Changes in Working Capital	0.05	0.93	0.26	0.74
Cash from Operating Activities	-16.39	-11.97	-6.24	-5.89
Capital Expenditures	-0.48	-0.72	-0.15	-0.05
Other Investing Cash Flow Items, Total	-9.97	1.20	-1.52	-0.05
Cash from Investing Activities	-10.46	0.48	-1.67	-0.10
Financing Cash Flow Items	0.00	0.02	0.00	0.00
Total Cash Dividends Paid	-	-	-	-
Issuance (Retirement) of Stock, Net	37.43	0.65	28.54	2.02
Issuance (Retirement) of Debt, Net	-	0.00	0.00	0.00
Cash from Financing Activities	37.43	0.67	28.54	2.02
Foreign Exchange Effects	-	-	-	-
Net Change in Cash	10.59	-10.82	20.63	-3.98
Cash Interest Paid, Supplemental	0.00	0.00	0.00	0.06
Cash Taxes Paid, Supplemental	0.00	0.00	0.00	0.00

Stock Information

Symbol: PBTH Prolor Biotech, Inc.
Last Price	6.43
Change	0.00
Bid	N/A
Ask	N/A
High	N/A
Low	May 22 - 6.43
Volume	0
Last Update	5/23/2013 7:30:22 AM

Media

A Video Overview of PROLOR Biotech

Video Interview with Shai Novik, President of PROLOR Biotech

Prolor Biotech

Financials

Stock Information

Prolor Biotech, Inc.

Media